Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » CXO integrated leader WuXi PharmaTech has strong performance growth, plans to increase capital expenditure of 10 billion in 2022